This session highlights cutting-edge research in Hepatitis C treatment, including next-generation antivirals, optimized therapy durations, and strategies for long-term patient outcomes post-cure. Presenters will share findings from clinical trials, modeling studies, and translational research aimed at advancing the future of HCV care.
Describe emerging antiviral agents and combination regimens for Hepatitis C.
Discuss updates on long-term outcomes related to novel HCV therapies.
Identify predictive tools and post-cure interventions aimed at reducing long-term liver-related complications and advancing HCV-related cancer prevention.